NCT01005641

ELBA: Exemestane and Lapatinib in Advanced Breast Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE2

Sponsor: National Cancer Institute, Naples

Condition: Breast Cancer

Signal summary

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

Study not started for administrative reasons